Advertisement
Singapore markets open in 2 hours 32 minutes
  • Straits Times Index

    3,176.51
    -11.15 (-0.35%)
     
  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     
  • Dow

    37,986.40
    +211.00 (+0.56%)
     
  • Nasdaq

    15,282.01
    -319.49 (-2.05%)
     
  • Bitcoin USD

    64,975.43
    +234.82 (+0.36%)
     
  • CMC Crypto 200

    1,344.68
    +32.06 (+2.44%)
     
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • Gold

    2,398.50
    -15.30 (-0.63%)
     
  • Crude Oil

    83.26
    +0.12 (+0.14%)
     
  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     
  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     
  • Hang Seng

    16,224.14
    -161.76 (-0.99%)
     
  • FTSE Bursa Malaysia

    1,547.57
    +2.81 (+0.18%)
     
  • Jakarta Composite Index

    7,087.32
    -7,166.81 (-50.28%)
     
  • PSE Index

    6,443.00
    -80.19 (-1.23%)
     

Gilead Sciences to Present at Upcoming Investor Conferences

FOSTER CITY, Calif., February 20, 2024--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:

  • TD Cowen Annual Health Care Conference on Tuesday, March 5 at 12:50pm Eastern Time

  • Leerink Partners Global Biopharma Conference on Tuesday, March 12 at 10:00am Eastern Time

  • Barclays Annual Global Healthcare Conference on Wednesday, March 13 at 11:15am Eastern Time

The live webcasts can be accessed at the company’s investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation.

ADVERTISEMENT

About Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240220712986/en/

Contacts

Jacquie Ross, CFA – Investors
investor_relations@gilead.com